-+ 0.00%
-+ 0.00%
-+ 0.00%

METAGENOMI THERAPEUTICS ANNOUNCES FDA CLEARANCE OF INVESTIGATIONAL NEW DRUG APPLICATION FOR MGX-001 AND REPORTS THIRD QUARTER 2026 FINANCIAL RESULTS

Reuters·11/10/2026 21:05:06

Please log in to view news